Reply to "Better method for evaluating a new laboratory test for syphilis"
Clin Vaccine Immunol
.
2015 May;22(5):607-8.
doi: 10.1128/CVI.00109-15.
Authors
Martin Enders
1
,
Michael Gleich
2
,
Annelies Mühlbacher
3
,
Tasanee Sakuldamrongpanich
4
,
Ajda Turhan
5
,
Rüchan Sertöz
5
,
Simona Semprini
6
,
Vittorio Sambri
7
Affiliations
1
Laboratory of G. Enders & Colleagues, MZV and Institute of Virology, Infectious Diseases and Epidemiology e. V., Stuttgart, Germany.
2
Labor Schottdorf MZV GmbH, Augsburg, Germany.
3
Central Institute for Blood Transfusion and Immunology, Innsbruck, Austria.
4
Thai Red Cross Society, Bangkok, Thailand.
5
Faculty of Medicine, Ege University, Smyrna, Turkey.
6
The Greater Romagna Area Hub Laboratory, Unit of Microbiology, Pievesestina, Cesena, Italy.
7
The Greater Romagna Area Hub Laboratory, Unit of Microbiology, Pievesestina, Cesena, Italy
[email protected]
.
PMID:
25921469
PMCID:
PMC4412951
DOI:
10.1128/CVI.00109-15
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Bacterial / blood*
Diagnostic Tests, Routine / methods*
Humans
Syphilis / diagnosis*
Treponema pallidum / immunology*
Substances
Antibodies, Bacterial